Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

NCT01489189 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

305

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

OTHER: Prompt Panretinal Photocoagulation
DRUG: 0.5-mg Ranibizumab
OTHER: Deferred panretinal photocoagulation

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]